Impact of inducible nitric oxide synthase gene on tumor progression

European Journal of Cancer Prevention

Volumn 18, Issue 1, 2009, Pages 1-8

  Tatemichi, Masayuki ^a   Ogura, Tsutomu ^b   Esumi, Hiroyasu ^c  

^a SHOWA UNIVERSITY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Inducible nitric oxide synthase; Invasion; Matrix metalioproteinase; Tumor cell

Indexed keywords

BENZO[A]PYRENE; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLASTIC; PYRENE; STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER INVASION; ENZYME DEFICIENCY; FOREIGN BODY; GENE ACTIVITY; GENE FUNCTION; INJECTION SITE; MALE; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; SUBCUTANEOUS TISSUE; TUMOR CELL CULTURE; TUMOR GENE; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NITRIC OXIDE SYNTHASE TYPE II; SKIN NEOPLASMS; STROMAL CELLS; SUBCUTANEOUS TISSUE;

EID: 58149250154     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f75f29     Document Type: Article

References (50)

1. Aaltoma SH, Lipponen PK, Kosma VM (2001). Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 21:3101-3106.
2. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hin SP, et al. (1998). p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4:1371-1376.
3. Balbin M, Fueyo A, Knauper V, Pendas AM, Lopez JM, Jimenez MG, et al. (1998). Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus. J Biol Chem 273:23959-23968.
4. Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, et al. (2001). Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem 276:10253-10262.
5. Bauer P, Russell J, Granger DN (1999). Role of endotoxin in intestinal reperfusion-induced expression of E-selectin. Am J Physiol Gastrointest Liver Physiol 276:G479-G484.
6. Bing RJ, Miyataka M, Rich KA, Hanson N, Wang X, Slosser HD, et al. (2001). Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 7:3385-3392.
7. Bogdan C (2001). Nitric oxide and the regulation of gene expression. Trends Cell Biol 11:66-75.
8. Broholm H, Braendstrup O, Lauritzen M (2001). Nitric oxide synthase expression of oligodendrogliomas. Clin Neuropathol 20:233-238.
9. Calmels S, Hainaut P, Ohshima H (1997). Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57:3365-3369.
10. Eberhardt W, Beeg T, Beck KF, Walpen S, Gauer S, Bohles H, et al. (2000). Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57:59-69.
11. Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, et al. (2000). Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6: 4768-4775.
12. Fitzpatrick FA (2001). Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1:1651-1667.
13. Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, et al. (2002). Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 101:415-422.
14. Ishii Y, Ogura T, Tatemichi M, Fujisawa H, Otsuka F, Esumi H (2003). Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int J Cancer 103: 161-168.
15. Juang SH, Xie K, Xu L, Wang Y, Yoneda J, Fidler IJ (1997). Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma. Cancer Biother Radiopharm 12:167-175.
16. Kawanishi S, Hiraku Y, Pinlaor S, Ma N (2006). Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387:365-372.
17. Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, et al. (1999). Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 70:222-229.
18. Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG (2001). Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res 61:3182-3187.
19. Laubach VE, Shesely EG, Smithies O, Sherman PA (1995). Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688-10692.
20. Lechner M, Lirk P, Rieder J (2005). Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 15: 277-289.
21. Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendling C, LeMeur M, et al. (1992). The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 119:997-1002.
22. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE (1994). Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A 91:4190-4194.
23. Li CO, Trudel LJ, Wogan GN (2002). Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc Natl Acad Sci U S A 99: 10364-10369.
24. Li F, Strange R, Friis RR, Djonov V, Altermatt HJ, Saurer S, et al. (1994). Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse. Int J Cancer 59:560-568.
25. Lyons CR, Orloff GJ, Cunningham JM (1992). Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267:6370-6374.
26. Madlener M, Werner S (1997). cDNA cloning and expression of the gene encoding murine stromelysin-2 (MMP-10). Gene 202:75-81.
27. Masure S, Nys G, Fiten P, Van Damme J, Opdenakker G (1993). Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylate in WEHI-3 macrophages and gene organisation. Eur J Biochem 218:129-141.
28. Murata J, Tada M, Iggo RD, Sawamura Y, Shinohe Y, Abe H (1997). Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat Res 379:211-218.
29. Ohshima H, Tatemichi M, Sawa T (2003). Chemical basis of inflammationinduced carcinogenesis, Arch Biochem Biophys 417:3-11.
30. Okada F, Hosokawa M, Hamada J, Hasegawa J, Mizutani M, Takeichi N, Kobayashi H (1993). Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates. Jpn J Cancer Res 84:1230-1236.
31. Okada F, Kawaguchi T, Habelhah H, Kobayashi T, Tazawa H, Takeichi N, et al. (2000). Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab Invest 80:1617-1628.
32. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H (2001). Activation of matrix metalloproteinases by peroxynitrite-induced protein S glutathiolation via disulfide S-oxide formation. J Biol Chem 276: 29596-29602.
33. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK (1999). Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 81:889-896.
34. Parsonnet J (2001). Microbes and malignancy. Infection as a cause of human cancers. New York, Oxford: Oxford University Press.
35. Pignatelli B, Bancel B, Esteve J, Malaveille C, Calmels S, Correa P, et al. (1998). Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous iesions in humans. Eur J Cancer Prev 7:439-447.
36. Pisani P, Parkin DM, Munoz N, Ferlay J (1997). Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6: 387-400.
37. Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM (2000). Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand J Gastroenterol 35:1204-1211.
38. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ (1993). Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci U S A 90:1013-1017.
39. Shi Q, Huang S, Jiang W, Kutach LS, Ananthaswamy HN, Xie K (1999). Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res 59:2072-2075.
40. Shi Q, Xiong Q, Wang B, Le X, Khan NA, Xie K (2000). Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res 60:2579-2583.
41. Shimizu Y, Nakatsuru Y, Ichinose M,Takahashi Y, Kume H, Mimura J, et al. (2000). Benzolalpyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 97:779-782.
42. Son K, Kim YM (1995). In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Cancer Res 55:5524-5527.
43. Tatemichi M, Ogura T, Nagata H, Esumi H (1998). Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia. J Clin Gastroenterol 27:240-245.
44. Tazawa H, Tatemichi M, Sawa T, Gilibert I, Ma N, Hiraku Y, et al. (2007). Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53 + / - mice. Carcinogenesis 28: 191-198.
45. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S (1986). Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 14:2829.
46. Tschugguel W, Schneeberger C, Untried G, Czerwenka K, Weninger W, Mildner M, et al. (1 999). Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 56:145-151.
47. Vallance P (2001). Nitric oxide. Biologist (London) 48:153-158.
48. Wei D, Richardson EL, Zhu K, Wang L, Le X, He Y, et al. (2003). Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res 63:3855-3659.
49. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM (1995). The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell 6:851-869.
50. Yamaguchi K, Saito H, Oro S, Tatebe S, Ikeguchi M, Tsujitani S (2005). Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68:471-478.